Stryker Corporation (SYK)

Stryker Corporation (SYK) is a healthcare company (medical devices) based in the United States. The share price is $317.64, up 2.23% on the day, which values the company at $120.92B. Price as of 17 Nov 2026, 18:25 UTC, from Yahoo Finance.

Key facts

Share price
$317.64+2.23% today
Market value
$120.92B
P/E ratio
33.8×last 12 months
Forward P/E
19.5×
Dividend yield
1.13%
Funk Score
63/100
Against its own history
Above its usual priceusual price $286.34
200-week average
$333.945% below

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Stryker Corporation in more detail

SYK trades at 33.8× its last twelve months' earnings, 19.5× next year's expected earnings, 4.6× sales. Measured against its own history, the price is 11% above what its usual multiples would imply ($286.34) — above its usual price. It sits 5% below its 200-week average of $333.94.

Over the last five fiscal years Stryker Corporation has compounded revenue 11.8% a year, earnings per share 14.9% a year, free cash flow 9.0% a year. Its Funk Score is 63 out of 100 (financial strength 5.7, profitability 7.5, growth 6.9, value 5.1, each out of 10).

In its favour: Altman Z in the safe zone; Five straight years of revenue growth. Worth checking: Share count keeps rising.

8 of the superinvestors tracked here hold SYK, including Terry Smith (5.7% of the portfolio), Jensen team (3.1% of the portfolio), Diamond Hill team (1.5% of the portfolio).

Superinvestors holding SYK

8 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:SYK vs MCK (Stryker Corporation vs McKesson)SYK vs BMY (Stryker Corporation vs Bristol-Myers Squibb)SYK vs MDT (Stryker Corporation vs Medtronic)SYK vs SNY (Stryker Corporation vs Sanofi)SYK vs MRNA (Stryker Corporation vs Moderna)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Stryker Corporation (SYK): questions and answers

What is SYK's P/E ratio?

Stryker Corporation trades at 33.8× its last twelve months' earnings and 19.5× next year's expected earnings. At its fiscal year-ends over the past 19 years the P/E ranged from 14.4× to 70.4×, with a median of 30.6×.

What is SYK's PEG ratio?

Stryker Corporation's PEG ratio is 1.49 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Stryker Corporation's market cap?

Stryker Corporation is valued at $120.92B at a share price of $317.64.

Is SYK overvalued or undervalued?

Against its own history, SYK is above its usual price: the price is 11% above the $286.34 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is SYK above its 200-week moving average?

No. SYK is 4.9% below its 200-week average of $333.94. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Stryker Corporation growing?

Over the last five fiscal years Stryker Corporation's revenue grew 11.8% a year and its earnings per share 14.9% a year; over ten years revenue grew 9.7% a year.

Cite this page

Funkfolio, “Stryker Corporation (SYK) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SYK

Underlying data: Yahoo Finance; company filings with the SEC.